Confluent [CFLT] vs Klaviyo [KVYO] Detailed Stock Comparison
Confluent
NASDAQ
Loading...
Klaviyo
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 18 vital metrics comparison: Confluent wins in 4 metrics, Klaviyo wins in 12 metrics, with 0 ties. Klaviyo appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Confluent | Klaviyo | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -15.26 | N/A | N/A |
| Price-to-Book Ratio | 5.41 | 7.95 | Confluent |
| Debt-to-Equity Ratio | 104.15 | 9.65 | Klaviyo |
| PEG Ratio | 47.81 | 54.82 | Confluent |
| EV/EBITDA | -13.68 | -105.73 | Klaviyo |
| Profit Margin (TTM) | -29.28% | -4.70% | Klaviyo |
| Operating Margin (TTM) | -34.16% | -8.49% | Klaviyo |
| Return on Equity | -32.18% | -4.73% | Klaviyo |
| Return on Assets (TTM) | -9.28% | -4.36% | Klaviyo |
| Free Cash Flow (TTM) | $9.49M | $148.73M | Klaviyo |
| 1-Year Return | -16.68% | 13.57% | Klaviyo |
| Price-to-Sales Ratio (TTM) | 5.42 | 9.06 | Confluent |
| Enterprise Value | $5.11B | $7.69B | Klaviyo |
| EV/Revenue Ratio | 4.80 | 7.63 | Confluent |
| Gross Profit Margin (TTM) | 73.73% | 75.81% | Klaviyo |
| Revenue per Share (TTM) | $3 | $4 | Klaviyo |
| Earnings per Share (Diluted) | $-0.93 | $-0.17 | Klaviyo |
| Beta (Stock Volatility) | 0.96 | N/A | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Confluent vs Klaviyo Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Confluent | -3.54% | -4.51% | -34.43% | -17.13% | -43.60% | -40.07% |
| Klaviyo | -4.94% | 9.42% | 0.50% | 1.22% | -27.53% | -18.28% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Confluent | -16.68% | -49.16% | -63.32% | -63.32% | -63.32% | -63.32% |
| Klaviyo | 13.57% | 5.75% | 5.75% | 5.75% | 5.75% | 5.75% |
Performance & Financial Health Analysis: Confluent vs Klaviyo
| Metric | CFLT | KVYO |
|---|---|---|
| Market Information | ||
| Market Cap | $5.77B | $9.13B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 13,438,025 | 1,822,160 |
| 90 Day Avg. Volume | 7,968,922 | 1,360,137 |
| Last Close | $16.33 | $32.35 |
| 52 Week Range | $16.19 - $37.90 | $23.77 - $49.55 |
| % from 52W High | -56.91% | -34.71% |
| All-Time High | $94.97 (Nov 01, 2021) | $49.55 (Feb 10, 2025) |
| % from All-Time High | -82.81% | -34.71% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.20% | 0.33% |
| Quarterly Earnings Growth | 0.20% | 0.33% |
| Financial Health | ||
| Profit Margin (TTM) | -0.29% | -0.05% |
| Operating Margin (TTM) | -0.34% | -0.08% |
| Return on Equity (TTM) | -0.32% | -0.05% |
| Debt to Equity (MRQ) | 104.15 | 9.65 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $3.09 | $3.86 |
| Cash per Share (MRQ) | $5.63 | $3.22 |
| Operating Cash Flow (TTM) | $42.19M | $154.14M |
| Levered Free Cash Flow (TTM) | $174.88M | $166.37M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Confluent vs Klaviyo
| Metric | CFLT | KVYO |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -15.26 | N/A |
| Forward P/E | 47.81 | 54.82 |
| PEG Ratio | 47.81 | 54.82 |
| Price to Sales (TTM) | 5.42 | 9.06 |
| Price to Book (MRQ) | 5.41 | 7.95 |
| Market Capitalization | ||
| Market Capitalization | $5.77B | $9.13B |
| Enterprise Value | $5.11B | $7.69B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 4.80 | 7.63 |
| Enterprise to EBITDA | -13.68 | -105.73 |
| Risk & Other Metrics | ||
| Beta | 0.96 | N/A |
| Book Value per Share (MRQ) | $3.09 | $3.86 |
Financial Statements Comparison: Confluent vs Klaviyo
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | CFLT | KVYO |
|---|---|---|
| Revenue/Sales | $282.29M | $293.12M |
| Cost of Goods Sold | $74.17M | $71.24M |
| Gross Profit | $208.12M | $221.88M |
| Research & Development | $121.22M | $72.46M |
| Operating Income (EBIT) | $-96.44M | $-31.33M |
| EBITDA | $-89.09M | $-27.40M |
| Pre-Tax Income | $-75.33M | $-22.48M |
| Income Tax | $6.62M | $1.80M |
| Net Income (Profit) | $-81.95M | $-24.28M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | CFLT | KVYO |
|---|---|---|
| Cash & Equivalents | $278.56M | $888.43M |
| Total Current Assets | $2.34B | $1.01B |
| Total Current Liabilities | $529.87M | $192.82M |
| Long-Term Debt | $1.10B | $84.12M |
| Total Shareholders Equity | $1.03B | $1.06B |
| Retained Earnings | $-2.06B | $-859.27M |
| Property, Plant & Equipment | $7.92M | $90.82M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | CFLT | KVYO |
|---|---|---|
| Operating Cash Flow | $28.41M | $36.85M |
| Capital Expenditures | $-1.43M | $-2.69M |
| Free Cash Flow | $-32.99M | $6.62M |
| Debt Repayment | N/A | $0 |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | CFLT | KVYO |
|---|---|---|
| Shares Short | 22.34M | 5.64M |
| Short Ratio | 4.12 | 4.03 |
| Short % of Float | 0.08% | 0.05% |
| Average Daily Volume (10 Day) | 13,438,025 | 1,822,160 |
| Average Daily Volume (90 Day) | 7,968,922 | 1,360,137 |
| Shares Outstanding | 332.89M | 272.76M |
| Float Shares | 280.61M | 94.16M |
| % Held by Insiders | 0.04% | 0.01% |
| % Held by Institutions | 0.94% | 1.17% |
Dividend Analysis & Yield Comparison: Confluent vs Klaviyo
| Metric | CFLT | KVYO |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |